Full video transcriptClick to expand
Auto-generated transcript of @trtstrong's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:01Coming to you from the great outdoors to continue my TRT story and the side effects that I have
- 0:06dealt with being on testosterone replacement therapy how I have treated them side effects in the past and what I'm currently doing to treat them side effects
- 0:14a little hint there
- 0:16so I will clarify all of the
- 0:19All of this by saying hi to common side effects that you're gonna have being on TRT
- 0:24Are you possibly gonna have is a elevated blood pressure and
- 0:27High-humatica levels or blood thickness. I will say that before I ever got on TRT
- 0:33I had already had slightly elevated blood pressure and my homatica levels were on the higher side so
- 0:40Being on TRT it can if you already have them issues it can aggravate it possibly
- 0:46Or if you don't have them issues you possibly could have them issues once you're on TRT
- 0:51It's just a possible side effect. So anyway have I dealt with them issues well in the past and currently
- 0:57I am still on a blood pressure pill one a day
- 1:00When it comes to high-humatica levels
- 1:04You know, it's kind of described as the blood being like sludge or mud
- 1:08It's just too thick when them levels are too high and it can't be good for the heart so
- 1:13The only good way to treat is to go and donate blood which I have done when I first got on TRT
- 1:19I had to do donations for you know several weeks in a row just to keep them levels or get them down
- 1:24After that I was kind of good for about six months
- 1:29Here in the last few months maybe last six months I have had to go back and donate to
- 1:34Get things back in a decent normal level. So
- 1:39That's what I've done in the past also with a combination of taking some aspirin just to
- 1:45Just to make sure I'm good. What am I currently doing?
- 1:48So a product that I got to doing some digging online on tiktok. I found it imagine that
- 1:55Product called a hemaflow
- 1:57Get you a good
- 2:00Good look at that. So hemaflow made by Leviathan nutrition
- 2:05Product specifically designed for you know guys like us on TRT that you know to keep them
- 2:12Hematically levels in check the blood pressure and check along with other, you know common related areas
- 2:18So again guys this is what I'm currently doing in the hopes of reducing if you know not doing away with the
- 2:25Having to take the blood pressure pill and the blood donation. So
- 2:29You know how it works. I'm going to put a link
- 2:32Should be right about in that area there gonna link to the product guys do your own research
- 2:38I mean I'm always gonna tell you you know don't start taking anything based on what someone else says without doing your research
- 2:45But I believe this is a good product
- 2:47Started it. I've got it started myself. So click the link below. Let me know what you think guys have a great day
TRT side effects and hematocrit: what the evidence says
Quick answer
The creator describes managing two common TRT side effects, erythrocytosis and hypertension, both of which he had at baseline before starting testosterone therapy. He is currently on an antihypertensive medication and has used therapeutic phlebotomy repeatedly, but is now supplementing with an unvalidated commercial product (Hemaflow) with the stated goal of potentially eliminating his prescription medication and donation schedule. This is a clinically unsupported strategy that should be discussed with a licensed provider before any medication changes are made.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 3 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT side effects and hematocrit: what the evidence says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT side effects and hematocrit: what the evidence says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "TRT side effects and hematocrit: what the evidence says" from trtstrong. We read the clip as a TRT social video fact-checks claim about Testosterone, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator describes managing two common TRT side effects, erythrocytosis and hypertension, both of which he had at baseline before starting testosterone therapy.
The reason this review is not generic is the source wording and the canonical claim label "trt testosterone replacement therapy side effects and treatments." In this clip, the useful excerpt is: "Coming to you from the great outdoors to continue my TRT story and the side effects that I have dealt with being on testosterone replacement therapy how I have treated them side effects in the past and what I'm currently doing to treat..." That wording changes the review because it points to Testosterone evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Cardiovascular Safety of Testosterone-Replacement Therapy (2023), Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline (2010), and Functional testosterone deficiency in aging men: Clinical impact, diagnostic pathways, and treatment strategies (2026), plus the creator's own wording. Testosterone decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
The creator describes managing two common TRT side effects, erythrocytosis and hypertension, both of which he had at baseline before starting testosterone therapy.
FormBlends verdict
Testosterone evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The creator describes managing two common TRT side effects, erythrocytosis and hypertension, both of which he had at baseline before starting testosterone therapy. He is currently on an antihypertensive medication and has used therapeutic phlebotomy repeatedly, but is now supplementing with an unvalidated commercial product (Hemaflow) with the stated goal of potentially eliminating his prescription medication and donation schedule. This is a clinically unsupported strategy that should be discussed with a licensed provider before any medication changes are made.
- Hematocrit above 54% is the standard AUA threshold for clinical intervention in TRT patients, including dose adjustment or therapeutic phlebotomy.
- Bhasin et al. (2021, NEJM) confirmed erythrocytosis as one of the most common dose-dependent adverse effects of testosterone therapy, particularly with injectable forms.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Hematocrit above 54% is the standard AUA threshold for clinical intervention in TRT patients, including dose adjustment or therapeutic phlebotomy.
- Bhasin et al. (2021, NEJM) confirmed erythrocytosis as one of the most common dose-dependent adverse effects of testosterone therapy, particularly with injectable forms.
- Repeated phlebotomy without iron monitoring can trigger compensatory erythropoiesis, potentially worsening the hematocrit elevation it is meant to treat.
- The 2023 TRAVERSE trial (Lincoff et al., NEJM) found no significant increase in major cardiovascular events with TRT, but did not evaluate unmonitored hematocrit management strategies.
- ACC/AHA guidelines no longer recommend routine low-dose aspirin for primary cardiovascular prevention in most adults due to bleeding risk exceeding benefit.
- No supplement currently has peer-reviewed evidence supporting its use as a replacement for antihypertensive medication in TRT patients.
- This video includes a direct TikTok Shop affiliate link to the promoted product, which is a material commercial relationship viewers should factor into how they evaluate the recommendation.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @trtstrong actually say?
The creator described two common TRT side effects, elevated blood pressure and high hematocrit, and walked through how he's managed both. He acknowledged pre-existing elevated blood pressure before starting TRT, which is worth noting. His past approach included therapeutic phlebotomy (blood donation) and low-dose aspirin. His current approach is a pivot: he's now taking a supplement called Hemaflow by Leviathan Nutrition, which he found on TikTok, in the hope of "reducing if not doing away with" his blood pressure medication and the need for blood donations.
That last part is where this video goes from personal testimony to something clinically concerning. He's not just sharing a product. He's framing a dietary supplement as a potential replacement for a prescribed antihypertensive medication. He does tell viewers to "do your own research," but the overall message is clear: click the link, this product might replace your meds.
Does the science back this up?
On the core side effects, yes. The evidence is solid. But on Hemaflow as a clinical intervention, there is essentially nothing peer-reviewed to evaluate.
TRT-associated erythrocytosis, meaning elevated hematocrit, is one of the most consistently documented side effects of testosterone therapy. A 2021 review by Bhasin et al. in the New England Journal of Medicine confirmed that hematocrit rises above 54% occur in a meaningful proportion of TRT users, particularly with injectable testosterone, and that therapeutic phlebotomy is the standard management approach. The creator's description of blood "like sludge" is informal, but it maps onto real concerns about increased blood viscosity and potential cardiovascular risk.
Blood pressure elevation on TRT is also real, though the magnitude is debated. A 2023 randomized controlled trial (Lincoff et al., NEJM) found no significant increase in major cardiovascular events in TRT users, but blood pressure monitoring remains standard of care. The aspirin mention is a separate issue. Routine aspirin for cardiovascular risk reduction without a specific indication is no longer recommended by most major guidelines, including the American College of Cardiology.
What did they get wrong (or right)?
Credit where it's due: the creator is honest that he had elevated blood pressure and borderline hematocrit before TRT. That kind of disclosure matters because it reframes TRT as a potential aggravating factor rather than a guaranteed cause. He also correctly identifies therapeutic phlebotomy as the primary management tool for high hematocrit, and that aligns with clinical guidelines from the American Urological Association.
Where this falls apart is the Hemaflow pivot. The product is marketed specifically for TRT users managing hematocrit and blood pressure, but there is no published clinical trial data on this formulation. The creator has been on it for a short time and has no outcome data to share. Presenting it as a reason to potentially stop a prescribed blood pressure medication is not "do your own research" territory. That is a medical decision that requires a provider.
The aspirin recommendation is also a quiet misstep. Aspirin as a general blood-thinning precaution for TRT users is not supported by current guidelines and carries real bleeding risk.
What should you actually know?
If you are on TRT and your hematocrit is climbing, the conversation needs to happen with your prescribing provider, not a TikTok comment section. Hematocrit above 54% is a standard threshold for dose adjustment or treatment pause under AUA guidelines. Therapeutic phlebotomy works, but it needs to be monitored because repeated donations can cause iron deficiency, which the body compensates for by producing even more red blood cells, potentially worsening the problem over time.
Blood pressure management on TRT is similarly individualized. If you need an antihypertensive, stopping it based on a supplement you found through a TikTok Shop link is a genuinely bad idea. Supplements can have real ingredient effects, but they are not FDA-reviewed for efficacy or safety in the way medications are, and their ingredient quality is not guaranteed.
- Get your hematocrit and blood pressure checked regularly if you are on TRT. Every 3 to 6 months is a common interval.
- Do not stop or taper a prescribed blood pressure medication without telling your doctor.
- Therapeutic phlebotomy is legitimate, but monitor iron levels if you are doing it frequently.
- Aspirin is not a standard or recommended tool for managing TRT-related blood viscosity.
- No supplement currently has peer-reviewed evidence demonstrating it reduces TRT-related erythrocytosis or replaces antihypertensives.
Is there a conflict of interest here?
Yes, and it's not subtle. The video is tagged with TikTok Shop, the creator is tagging the brand directly, and there is a purchase link in the description. That does not automatically make the product harmful, but it means this video is fundamentally an advertisement wrapped in a personal health story. The "do your own research" disclaimer does not change the commercial structure of the content. Viewers should weigh that context heavily before making any health decisions based on what they watched.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
trtstrong · TikTok creator
66.4K views on this video
Testosterone Replacement Therapy Side Effects and Treatments #testosterone #trt #sideeffects #hemoflow #hormonetherapy #hematocrit #bloodpressure #mystory #myexperience #tictokshop #fy #fyp #menshealth #treatments #blooddonation #viral #testosteronetherapy @Leviathan Nutrition
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about hematocrit above 54%?
Hematocrit above 54% is the standard AUA threshold for clinical intervention in TRT patients, including dose adjustment or therapeutic phlebotomy.
What does the video say about bhasin et al. (2021, nejm) confirmed erythrocytosis as one of?
Bhasin et al. (2021, NEJM) confirmed erythrocytosis as one of the most common dose-dependent adverse effects of testosterone therapy, particularly with injectable forms.
What does the video say about repeated phlebotomy without iron monitoring can trigger compensatory erythropoiesis, potentially?
Repeated phlebotomy without iron monitoring can trigger compensatory erythropoiesis, potentially worsening the hematocrit elevation it is meant to treat.
What does the video say about the 2023 traverse trial (lincoff et al., nejm) found no?
The 2023 TRAVERSE trial (Lincoff et al., NEJM) found no significant increase in major cardiovascular events with TRT, but did not evaluate unmonitored hematocrit management strategies.
What does the video say about acc/aha guidelines no longer recommend routine low-dose aspirin for primary?
ACC/AHA guidelines no longer recommend routine low-dose aspirin for primary cardiovascular prevention in most adults due to bleeding risk exceeding benefit.
What does the video say about no supplement currently has peer-reviewed evidence supporting its use as?
No supplement currently has peer-reviewed evidence supporting its use as a replacement for antihypertensive medication in TRT patients.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by trtstrong, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.